Main Menu

Natera, Inc.

(NASDAQ GS: NTRA)

Rigrodsky Law, P.A. is investigating Natera, Inc. (“Natera” or the "Company”) and certain of its officers for issuing materially false and misleading statements during the Class Period (February 26, 2020 and April 19, 2022, inclusive) concerning the Company’s non-invasive prenatal test, Panorama, and Natera’s screening test for kidney transplant failure, Prospera, in possible violation of the federal securities laws.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 07/05/2022


* Indicates a required field.

Back to Page